● Recruiting

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Condition: Bronchiectasis With Pseudomonas Aeruginosa Colonization · Sponsor: AstraZeneca

PhasePhase 2

Planned participants435

Who can joinAll sexes, 12 Years to no upper limit

Healthy volunteersNo

About this study

AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (185)

Research Site	Orange, California, United States	Recruiting
Research Site	San Francisco, California, United States	Recruiting
Research Site	Denver, Colorado, United States	Not Yet Recruiting
Research Site	Washington D.C., District of Columbia, United States	Recruiting
Research Site	Jacksonville, Florida, United States	Recruiting
Research Site	Miami Lakes, Florida, United States	Suspended
Research Site	Naples, Florida, United States	Recruiting
Research Site	Ormond Beach, Florida, United States	Recruiting
Research Site	Plantation, Florida, United States	Recruiting
Research Site	Rincon, Georgia, United States	Recruiting
Research Site	Kansas City, Kansas, United States	Recruiting
Research Site	Ann Arbor, Michigan, United States	Recruiting

+ 173 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07088926